UroGen Pharma Ltd. (NASDAQ:URGN) Q4 2022 Earnings Call Transcript

UroGen Pharma Ltd. (NASDAQ:URGN) Q4 2022 Earnings Call Transcript March 16, 2023

Operator: Good day and thank you for standing by. And welcome to the UroGen Pharma Q4 2022 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there’ll be a question-and-answer session. Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker today, Vincent Perrone, Head of Investor Relations....